Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.
about
Essential thrombocythemiaGuidelines for the management of myeloproliferative neoplasmsA single institutional experience with 43 pregnancies in essential thrombocythemiaPractical management of classical myeloproliferative disorder patients: a clinician's guideEssential thrombocytemia and acute coronary syndrome: clinical profile and association with other thromboembolic eventsPostpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature.Aortic thrombus in a patient with myeloproliferative thrombocytosis, successfully treated by pharmaceutical therapy: a case report.The optimal management of polycythaemia vera.How we diagnose and treat essential thrombocythaemia.Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centers.Cardiac surgery in a patient with essential thrombocythemia: a case report.Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients.Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis.
P2860
Q21202968-53A0A3AB-A6B4-4127-9499-B81E7EF6D475Q26778326-BD053953-2A2D-4559-9A82-A42386C667C4Q28183482-B10C7EB8-0BF6-4135-89CC-30C1D32D636BQ28200207-0E7073EF-4BEB-4BB2-8CE7-1E15364B8100Q28222363-D7D5E6C2-DE6E-4835-80E4-0B93802C870DQ34016598-30DFE194-E9E1-4E73-8A97-CD4813207BB5Q34057620-550B6FF9-8C98-402F-9597-FA392447CB8CQ34527669-FC8D5DC8-85E4-466F-ABA3-165AF6AAF050Q38606595-A039132B-992B-4D97-B9F9-39CAD5149D08Q41155968-0AD07AD1-1A53-4267-8B3B-08344D629BE1Q41253192-436259B5-1004-4AF7-955F-F6547372B12AQ41789285-19478E93-C877-4C12-9124-0381226C0A7EQ43910566-1D387847-2F74-4C44-93C9-A085C8C8916EQ44103821-E36478A7-FC13-4533-901C-1138D372CCCDQ51032125-ECB8A383-7214-4E17-89DF-0E872FF6C20D
P2860
Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Vascular complications of esse ...... o cardiovascular risk factors.
@en
Vascular complications of esse ...... o cardiovascular risk factors.
@nl
type
label
Vascular complications of esse ...... o cardiovascular risk factors.
@en
Vascular complications of esse ...... o cardiovascular risk factors.
@nl
prefLabel
Vascular complications of esse ...... o cardiovascular risk factors.
@en
Vascular complications of esse ...... o cardiovascular risk factors.
@nl
P2860
P1476
Vascular complications of esse ...... to cardiovascular risk factors
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.1993.TB08272.X
P407
P577
1993-02-01T00:00:00Z